STOCK TITAN

Sealsq Corp SEC Filings

LAES NASDAQ

SEALSQ Corp filings document the disclosures of a British Virgin Islands foreign private issuer developing semiconductor, PKI and post-quantum security products. Its Form 6-K reports furnish annual report materials, operating and financial results, AGM notices and outcomes, governance votes, and product or certification updates for secure-element and post-quantum hardware programs.

The filing record also covers registered direct offering documents, securities purchase and placement agency agreements, ordinary shares, pre-funded warrants, Class E warrants, shelf registration references and equity incentive registration statements. These disclosures describe capital-structure changes, material agreements, liquidity and revenue commentary, board composition, and shareholder voting mechanics.

Rhea-AI Summary

Amendment No. 1 to Schedule 13G shows that WISeKey International Holding AG now holds 6,001,200 SEALSQ Corp (LAES) ordinary shares, equating to 4.85 % of the 123.7 million shares outstanding as of 30 Jun 2025. Because the economic stake has fallen below the 5 % threshold, Item 5 is tick-marked “Ownership of 5 percent or less.”

Despite the smaller ordinary-share position, WISeKey also owns 1,499,700 Class F shares. When combined with the ordinary shares, this block delivers 52.41 % of SEALSQ’s total voting power, leaving WISeKey in effective control of shareholder decisions. All voting and dispositive power over the disclosed ordinary shares is sole; there is no shared power reported.

The filing is informational only—no purchase, sale or agreement is disclosed—and is made under Rule 13d-1(c). Certified by CEO Carlos Moreira and CFO John O’Hara on 29 Jul 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

SEALSQ Corp (NASDAQ: LAES) has entered into a definitive agreement to raise approximately $60 million through a registered direct offering. On 14 July 2025 the company signed a Securities Purchase Agreement with institutional investors to issue 15 million Ordinary Shares at a combined price of $4.00 per share, each accompanied by one Class A and one Class B warrant.

Both warrant series are immediately exercisable, expire on 15 July 2032 and carry an exercise price of $4.60. Full exercise would add a further 30 million shares, taking total potential issuance to 45 million. The warrants include anti-dilution adjustments, cashless-exercise mechanics and a 4.99% (optionally 9.99%) beneficial-ownership cap. Class A warrants feature an additional Black-Scholes cash-put right upon a qualifying Fundamental Transaction.

Maxim Group LLC is acting as placement agent and will receive a 7% fee on gross proceeds plus up to $40,000 in reimbursable expenses. The transaction is being conducted under SEALSQ’s effective Form F-3 shelf (File No. 333-286098). Closing is expected on 15 July 2025, subject to customary conditions. The company does not intend to list the warrants on any exchange.

Investors gain clarity on near-term liquidity—net proceeds (after fees) will strengthen the balance sheet—yet face material dilution from the primary share issuance and any future warrant exercises.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many Sealsq (LAES) SEC filings are available on StockTitan?

StockTitan tracks 85 SEC filings for Sealsq (LAES), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Sealsq (LAES)?

The most recent SEC filing for Sealsq (LAES) was filed on July 29, 2025.